Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

August 30, 2013

Gilead Sciences, Inc. v. Merck & Co, Inc. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. July 17, 2017

    Gilead Wins $14M In Attys' Fees For Merck Patent Misconduct

    A California federal judge on Friday ordered Merck & Co. Inc. to pay Gilead Sciences Inc. $14 million in attorneys' fees after finding last year that Merck committed "numerous unconscionable acts" in a patent suit against Gilead that led her to wipe out a $200 million jury verdict.

17 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login